申请人:Array BioPharma Inc.
公开号:US08183289B2
公开(公告)日:2012-05-22
Compounds of Formula (I): in which R1, R2, R7, R8, R9, R10 and A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.
式(I)化合物:其中R1、R2、R7、R8、R9、R10和A具有规范中给定的含义,是DP2受体调节剂,可用于治疗免疫性疾病。